• About
    • Our Story
    • Our Vision/Mission
    • Our Team
    • Pressroom
  • For Families
    • What is LCA?
    • ID Your Gene
    • Clinical Trials
    • Resources
    • Rare Retinal Disease Glossary
    • Family Connections
    • Hope in Focus Ambassadors
    • Let’s Chat About…
  • Stories
    • Posts & Videos
    • Photo Gallery
  • Get Involved
    • Event Calendar
    • Donate
  • Contact
    • Get in Touch
    • Email & Newsletter Sign Up
    • Family Connections
  • DONATE
    Leber Congenital Amaurosis Leber Congenital Amaurosis Leber Congenital Amaurosis Leber Congenital Amaurosis
    • About
      • Our Story
      • Our Vision/Mission
      • Our Team
      • Pressroom
    • For Families
      • What is LCA?
      • ID Your Gene
      • Clinical Trials
      • Resources
      • Rare Retinal Disease Glossary
      • Family Connections
      • Hope in Focus Ambassadors
      • Let’s Chat About…
    • Stories
      • Posts & Videos
      • Photo Gallery
    • Get Involved
      • Event Calendar
      • Donate
    • Contact
      • Get in Touch
      • Email & Newsletter Sign Up
      • Family Connections
    • DONATE

    Archives

    Author Archive for: "Rosanne Smyle"
    0
    By Rosanne Smyle
    In News
    Posted May 25, 2022

    Former Pfizer Executive Appointed to Hope in Focus Board

    David Schulz has been appointed to our Board of Directors. He began his career at Pfizer Central Research as a Research Scientist in 1989 and was promoted to Executive Director […]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted April 26, 2022

    ProQR Announces Updates and Priorities After Illuminate Trial Analyses

    ProQR Therapeutics completed an in-depth strategic review to prioritize its objectives toward advancing RNA therapies, following news that its Illuminate Phase 2/3 clinical trial of sepofarsen in [...]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted April 4, 2022

    Let’s Chat About … Opus Genetics with Ben Yerxa

    Working with preclinical data from multiple Leber congenital amaurosis (LCA) studies at the same time, Opus Genetics hopes to advance research into gene therapy for several forms of LCA at a [...]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted March 29, 2022

    Let’s Chat About … Self-Advocacy and Supporting Your Child’s Education with Beth Borysewicz

    Children living with visual impairment become more independent and empowered when parents set high expectations for their kids and challenge them every day. Just ask Beth Borysewicz. In her role [...]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted March 9, 2022

    Mother of Toddler Living with LCA6 RPGRIP1 Collaborates with Biotech Odylia to Help Advance Gene Therapy Research

    After crazy months of looking for answers to questions about her infant’s vision, Melissa Matias learned her baby girl, Dylan, had a form of Leber congenital amaurosis known as LCA6 caused […]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted March 1, 2022

    LCA10 CEP290 Illuminate Clinical Trial Produces No Observed Benefit

    ProQR Therapeutics’ clinical trials of sepofarsen to treat a form of Leber congenital amaurosis (LCA) caused by a mutation in the CEP290 gene did not meet its primary endpoint of […]

    READ MORE
    0
    By Rosanne Smyle
    In News
    Posted February 25, 2022

    Hope In Focus Statement for Connecticut’s Rare Disease Day

    Celebrating Connecticut Rare Disease Day 2022, Hope in Focus presented remarks Friday, February 25, 2022, to the Connecticut State Legislature on behalf of those living with Leber congenital [...]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted February 25, 2022

    Rare Disease Day 2022: Hope in Focus Promotes Rare Disease Advisory Council

    Rare Disease Day 2022 kicked off today as people gathered across the country, including us here at Hope in Focus, to raise awareness and generate research for treatments and cures […]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted February 15, 2022

    BioBonds: Innovative legislation would help fund clinical trials, including those for LCA

    A proposed Congressional Act designed to help researchers launch clinical trials for emerging treatments gives hope for getting more treatments across the finish line for people living with a [...]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted January 28, 2022

    Let’s Chat About…ProQR’s Work in Treatments for Inherited Retinal Disease

    ProQR Therapeutics’ Founder and Chief Executive Officer shared exciting news of the deep pipeline of RNA therapies in development to treat Leber congenital amaurosis (LCA) and other [...]

    READ MORE
    1 2 3 4 5 6 7 8 9 ...
    page 1 of 11
    Sign Up for Our Newsletter
    NEWSLETTER SIGN UP
    Get In Touch
    • 860-266-6062
    • info@hopeinfocus.org
    Follow Us
    Hope in Focus is a 501(C)(3). © All rights reserved.
    Please read our Privacy Promise.
    Skip to content
    Open toolbar

    Accessibility Tools

    • Increase Text
    • Decrease Text
    • Grayscale
    • High Contrast
    • Negative Contrast
    • Light Background
    • Links Underline
    • Readable Font
    • Reset